77 related articles for article (PubMed ID: 1619317)
1. [Bone mineral content in premenopausal women treated with gonadotropin-releasing hormone analogue].
Masahashi T; Negoro Y; Asai M; Suzuki M; Noguchi M; Nakanishi M; Tomita A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):577-80. PubMed ID: 1619317
[TBL] [Abstract][Full Text] [Related]
2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
3. [Clinical application of luteinizing hormone releasing hormone agonist and its impact on bone metabolism].
Zhang M; He Y; Cao S
Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):398-401. PubMed ID: 7587574
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of the decrease in metacarpal bone mineral content due to oophorectomy].
Ohta H; Nemoto K; Nozawa S; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):333-40. PubMed ID: 2786542
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
Finkelstein JS; Klibanski A; Schaefer EH; Hornstein MD; Schiff I; Neer RM
N Engl J Med; 1994 Dec; 331(24):1618-23. PubMed ID: 7969342
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
7. Influence of sex and age on biochemical bone metabolism parameters.
Resch H; Pietschmann P; Kudlacek S; Woloszczuk W; Krexner E; Bernecker P; Willvonseder R
Miner Electrolyte Metab; 1994; 20(3):117-21. PubMed ID: 7815999
[TBL] [Abstract][Full Text] [Related]
8. [Changes in bone mineral content and bone metabolism related to menopause].
Ohta H; Nemoto K; Nozawa S; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1447-54. PubMed ID: 2584821
[TBL] [Abstract][Full Text] [Related]
9. Fractional calcium absorption is increased in girls with Rett syndrome.
Motil KJ; Schultz RJ; Abrams S; Ellis KJ; Glaze DG
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):419-26. PubMed ID: 16641581
[TBL] [Abstract][Full Text] [Related]
10. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment].
Chai R; Ye Z; Zhan Z
Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794
[TBL] [Abstract][Full Text] [Related]
11. [Determination of bone mineral content and correlations with calciotropic hormones in periodic hemodialysis patients].
Anelli F; De Maio P; Girardi V; Papagni S; Rossi G; Cantatore FP; Carrozzo M
Minerva Urol Nefrol; 1992; 44(4):265-73. PubMed ID: 1299008
[TBL] [Abstract][Full Text] [Related]
12. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women.
Yasui T; Uemura H; Tomita J; Miyatani Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
Maturitas; 2007 Mar; 56(3):288-96. PubMed ID: 17030103
[TBL] [Abstract][Full Text] [Related]
13. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
[TBL] [Abstract][Full Text] [Related]
14. Bone mass in endometriosis patients treated with GnRH agonist implant or danazol.
Dodin S; Lemay A; Maheux R; Dumont M; Turcot-Lemay L
Obstet Gynecol; 1991 Mar; 77(3):410-5. PubMed ID: 1825135
[TBL] [Abstract][Full Text] [Related]
15. Changes in bone mineral content following hormone treatment for endometriosis.
Fukushima M
Int J Gynaecol Obstet; 1995 Sep; 50 Suppl 1():S17-22. PubMed ID: 8529770
[TBL] [Abstract][Full Text] [Related]
16. Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy.
Greenspan SL; Holland S; Maitland-Ramsey L; Poku M; Freeman A; Yuan W; Kher U; Gertz B
Proc Assoc Am Physicians; 1996 May; 108(3):230-8. PubMed ID: 8774056
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival and corneal calcification and bone metabolism in hemodialysis patients.
Tokuyama T; Ikeda T; Sato K; Mimura O; Morita A; Tabata T
Am J Kidney Dis; 2002 Feb; 39(2):291-6. PubMed ID: 11840369
[TBL] [Abstract][Full Text] [Related]
19. Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3.
Scharla SH; Minne HW; Waibel-Treber S; Schaible A; Lempert UG; Wüster C; Leyendecker G; Ziegler R
J Clin Endocrinol Metab; 1990 Apr; 70(4):1055-61. PubMed ID: 2138629
[TBL] [Abstract][Full Text] [Related]
20. Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma.
Ito M; Sakoda Y; Okamura H
Endocrinol Jpn; 1990 Dec; 37(6):907-13. PubMed ID: 1966283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]